Covered recipient · General Payments record
SAMINA T SYED
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2019–2024
$620.44
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $218.77 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $55.48 | 3 |
| Insulet Corporation | $53.21 | 2 |
| Amgen Inc. | $42.87 | 3 |
| Neurocrine BioSciences, Inc. | $34.85 | 1 |
| Amphastar Pharmaceuticals, Inc. | $18.37 | 1 |
| ABBVIE INC. | $13.99 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.46 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125304761 | CMS |
| Abbott Laboratories | $19.40 | 08/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125304763 | CMS |
| Abbott Laboratories | $19.62 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125304765 | CMS |
| ABBVIE INC. | $13.99 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106191339 | CMS |
| Amgen Inc. | $16.15 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116165394 | CMS |
| Amgen Inc. | $13.20 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116165400 | CMS |
| Amgen Inc. | $13.52 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116165406 | CMS |
| Amphastar Pharmaceuticals, Inc. | $18.37 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149958787 | CMS |
| Insulet Corporation | $29.38 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116804986 | CMS |
| Insulet Corporation | $23.83 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116811729 | CMS |
| Neurocrine Biosciences, Inc. | $34.85 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150819114 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.